CDK4/6-dependent activation of DUB3 regulates cancer metastasis through SNAIL1

Tongzheng Liu(Mayo Clinic), Jia Yu(Mayo Clinic), Min Deng(Mayo Clinic), Yujiao Yin(Tongji University), Haoxing Zhang(Southwest University), Kuntian Luo(Tongji University), Bo Qin(Mayo Clinic), Yunhui Li(Tongji University), Chenming Wu(Tongji University), Tao Ren(Shanghai East Hospital), Han Yang(Shanghai East Hospital), Yin Peng(Mayo Clinic), Jung-Jin Kim(Mayo Clinic), SeungBaek Lee(Mayo Clinic), Jing Lin(First Affiliated Hospital of Chinese PLA General Hospital), Lizhi Zhang(Mayo Clinic), Jun Zhang(Mayo Clinic), Somaira Nowsheen(Mayo Clinic in Arizona), Liewei Wang(Mayo Clinic), Judy C. Boughey(Mayo Clinic), Matthew P. Goetz(Mayo Clinic), Jian Yuan(Tongji University), Zhenkun Lou(Mayo Clinic)
Nature Communications
January 9, 2017
Cited by 160Open Access
Full Text

Abstract

Tumour metastasis, the spread of cancer cells from the original tumour site followed by growth of secondary tumours at distant organs, is the primary cause of cancer-related deaths and remains poorly understood. Here we demonstrate that inhibition of CDK4/6 blocks breast tumour metastasis in the triple-negative breast cancer model, without affecting tumour growth. Mechanistically, we identify a deubiquitinase, DUB3, as a target of CDK4/6; CDK4/6-mediated activation of DUB3 is essential to deubiquitinate and stabilize SNAIL1, a key factor promoting epithelial-mesenchymal transition and breast cancer metastasis. Overall, our study establishes the CDK4/6-DUB3 axis as an important regulatory mechanism of breast cancer metastasis and provides a rationale for potential therapeutic interventions in the treatment of breast cancer metastasis.


Related Papers

No related papers found

Powered by citation graph analysis